Défis éthiques et réglementaires dans la recherche sur les tissus nerveux

Topic: Biocomputing. Dr. Fred Jordan discusses his childhood and professional development (02:09), the first company he cofounded, AlpVision, the world’s leader in digital invisible technologies for product authentication and counterfeit protection (04:07), the founding of FinalSpark (12:32), his inspiration for researching biocomputing (14:30), the principles and benefits of biocomputing (17:18), its applications (30:00), FinalSpark’s need for investment (38:39), the biocomputing regulatory field (43:05), his long-term vision for FinalSpark (44:47), and his view on Neuralink’s research (45:43).